Previous 10 | Next 10 |
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, C...
2023-11-07 11:40:20 ET InfuSystem Holdings, Inc. (INFU) Q3 2023 Earnings Conference Call November 07, 2023 09:00 AM ET Company Participants Joe Dorame - Managing Partner Rich DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lach...
2023-11-07 06:42:04 ET More on InfuSystem Seeking Alpha’s Quant Rating on InfuSystem Historical earnings data for InfuSystem Financial information for InfuSystem For further details see: InfuSystem GAAP EPS of $0.03, revenue of $31.9M
Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year Operating Income Increased 80% - Net Income Increased 56% - Adjusted EBITDA Increased 11% Raising Full Year 2023 Net Revenue Guidance InfuSystem Holdings, Inc. (NYSE American: ...
2023-11-06 14:50:14 ET More on InfuSystem Seeking Alpha’s Quant Rating on InfuSystem Historical earnings data for InfuSystem Financial information for InfuSystem For further details see: InfuSystem Q3 2023 Earnings Preview
2023-11-06 10:30:08 ET Major earnings expected before the bell on Tuesday include: Air Products and Chemicals ( APD ) Datadog ( DDOG ) D.R. Horton ( DHI ) Emerson Electric ( EMR ) Uber Technologies ( UBER ) For further details see: Notable...
Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactu...
2023-09-13 07:18:38 ET Summary CellerateRX was approved to be sold in over 1200 new locations. BIASURGE was approved by the FDA and is set to launch commercially in Q4. TEXAGEN sales growing extremely fast (86% QoQ). Second supplier of ALLOCYTE coming online to s...
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, C...
2023-08-07 23:20:00 ET Summary InfuSystem reported mixed results for its 2Q23 earnings, with revenue beating expectations but a lower adjusted EBITDA margin. The company's revenue in the first half of the year exceeded initial guidance, indicating strong business growth. Despi...
News, Short Squeeze, Breakout and More Instantly...
InfuSystems Holdings Inc. Company Name:
INFU Stock Symbol:
NYSE Market:
Investor Presentation to be held at 8:30 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactu...
A substantial acquisition of company stock options by Scott Shuda, Board Member at InfuSystems Holdings (AMEX:INFU) was reported on May 21, based o...
Paul A. Gendron, Director at InfuSystems Holdings (AMEX:INFU), reported acquisition of company stock options on May 21, according to a new SEC fili...